Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Immunopharma AS

Closing information (x1000 EUR)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 45,793 Less Arrow 39,181 Less Arrow 30,107
Financial expenses 924 More Arrow 1,000 More Arrow 1,120
Earnings before taxes -4,723 More Arrow -2,333 More Arrow -1,861
Total assets 36,210 Less Arrow 35,217 More Arrow 37,201
Current assets 21,841 Less Arrow 13,232 Less Arrow 9,891
Current liabilities 10,154 Less Arrow 7,466 Less Arrow 6,844
Equity capital 19,422 More Arrow 24,459 Less Arrow 13,126
- share capital 1,317 More Arrow 1,341 Less Arrow 990
Employees (average) 8 Less Arrow 1

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 53.6% More Arrow 69.5% Less Arrow 35.3%
Turnover per employee 4,898 More Arrow 30,107
Profit as a percentage of turnover -10.3% More Arrow -6.0% Less Arrow -6.2%
Return on assets (ROA) -10.5% More Arrow -3.8% More Arrow -2.0%
Current ratio 215.1% Less Arrow 177.2% Less Arrow 144.5%
Return on equity (ROE) -24.3% More Arrow -9.5% Less Arrow -14.2%
Change turnover 8,671 Less Arrow 7,438 More Arrow 29,885
Change turnover % 23% Equal arrow 23% More Arrow 13447%
Chg. No. of employees 7 Less Arrow 0
Chg. No. of employees % 700% Less Arrow 0%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.